Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Eyeing Opportunities In Micro-Cap Bio-Pharma Index
Dec 02, 2008 09:54 AM
- Achillion Pharma: Funding in Place to Advance HCV Pipeline
Nov 24, 2008 11:28 PM
- Emerging Biotech & Pharma Index: 36 More Cos.
Nov 24, 2008 01:40 AM
- The Week In Review: Biopharma News Back In The Forefront
Nov 23, 2008 12:24 PM
- Updated FDA Calendar Of 73 Decision Dates
Nov 22, 2008 12:57 PM
- GSK Signs Pre-JV Vaccine Pact with Shenzhen Neptunus Interlong
Nov 21, 2008 02:02 PM
- Regenerative Medicine: The Next Frontier for Big Pharma
Nov 17, 2008 12:19 PM
- A Backlog Of Decisions Is Building At The FDA
Nov 07, 2008 11:48 AM
- Virtual Funds: Healthcare Fund's Ranking/Performance In Q3 '08 And Overall
Nov 01, 2008 01:31 PM
- Biotech Portfolio Updates – Buying More Genentech And Exelixis
Oct 28, 2008 12:12 PM
- Triangle Jobless Rate Falls in October
Dec 02, 2008 12:57 PM
- Vanishing jobs, stressed consumers feed downturn
Nov 07, 2008 09:57 AM
- Vanishing jobs, stressed consumers feed downturn
Nov 07, 2008 06:58 AM
- Vanishing jobs, stressed consumers feed downturn
Nov 07, 2008 03:56 AM
- Vanishing jobs, stressed consumers feed downturn
Nov 07, 2008 12:59 AM
- Pharma Sales to Grow 1% to 2% in '09
Oct 30, 2008 05:56 AM
- Pharma Sales Outlook Lowered for '09
Oct 29, 2008 01:02 PM
- Seasonal Tobacco Jobs Drop County Unemployment Rate: More Business Layoffs Seen As Likely
Oct 25, 2008 04:12 PM
- Triangle Job Losses Mount: Jobless Rate Still Below State, Nation
Oct 25, 2008 06:57 AM
- Downturn Lands Direct Hit in N.C.
Oct 24, 2008 05:59 AM
- GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
Dec 04, 2008 07:00 PM
- GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.
Dec 03, 2008 04:30 PM
- FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
Nov 20, 2008 05:43 PM
- Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: NVS, JNJ, PFE, GSK, ABT, AZN
Nov 20, 2008 09:20 AM
- Study Published in Archives of Surgery Demonstrated Benefit of
ENTEREG® (alvimopan) in Postoperative Ileus
Nov 18, 2008 07:09 AM
- GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.
Nov 12, 2008 09:45 AM
- Zacks Analyst Blog Highlights: Sprint Nextel Corp., Ultrapar Participacoes SA, Eurand N.V., Cephalon, Inc. And GlaxoSmithKline Inc.
Nov 11, 2008 07:18 AM
- GSK and XenoPort Announce Plans to Withdraw and Resubmit New Drug Application Requesting Approval of Solzira(TM) for Restless Legs Syndrome
Nov 10, 2008 08:56 AM
- New Data Reveal People with Chronic Diseases are Unaware of Their Health Status
Nov 02, 2008 07:55 PM
- GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C
Oct 29, 2008 08:45 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
GSK
|
Compare to S&P
|
| YTD |
-32.78 %
|
-0.01 %
|
| 4 Weeks |
-8.36 %
|
0.27 %
|
| 12 Weeks |
-23.89 %
|
7.69 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -12.96 %
|
|
EPS Growth in Last Year: -2.08 %
|
|
Sales Growth in Last Quarter: -4.54 %
|
|
Sales Growth in Last Quarter: 0.82 %
|
|
|
